{"id":"W2774227900","doi":"10.1016/j.ejca.2017.10.021","title":"Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"F. Hoffmann-La Roche; Roche","keywords":"Pertuzumab; Anthracycline; Trastuzumab; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002932904,0.0003779013,0.001651593,0.0003422575,0.0005803299,0.0001261701,0.0005458033,0.00004772126,0.0001085092],"category_scores_gemma":[0.0004384793,0.0002377097,0.0002901438,0.0003942178,0.0006151546,0.0003065167,0.0002615075,0.0007698683,1.628172e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006893111,"about_ca_system_score_gemma":0.0008224472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006312401,"about_ca_topic_score_gemma":0.0004534345,"domain_scores_codex":[0.9954165,0.0009722508,0.001164802,0.0004866115,0.001504737,0.0004551047],"domain_scores_gemma":[0.9959635,0.0002571979,0.001538716,0.0008692293,0.001065003,0.0003063448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0806468,0.0006203529,0.6994997,0.00004876893,0.003111351,0.0001579506,0.008824017,0.0002534033,0.0004017852,2.874376e-7,0.00003087272,0.2064047],"study_design_scores_gemma":[0.1508611,0.00690232,0.8369601,0.001724548,0.002326074,0.00001853522,0.0004957706,0.0002483084,0.0002265923,4.888959e-7,0.00002513422,0.0002110326],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930708,0.002802335,0.00005407252,0.001784752,0.0002028187,0.001577295,0.0003471153,0.000007642526,0.00015312],"genre_scores_gemma":[0.9975265,0.001786866,0.0001041864,0.00009144741,0.0003052286,0.00001489056,0.000004198244,0.00008525248,0.00008139956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2061937,"threshold_uncertainty_score":0.969352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02363119783183756,"score_gpt":0.3797801121478566,"score_spread":0.356148914316019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}